174 related articles for article (PubMed ID: 38003522)
1. Role of ST6GAL1 in Thyroid Cancers: Insights from Tissue Analysis and Genomic Datasets.
Gunjača I; Benzon B; Pleić N; Babić Leko M; Pešutić Pisac V; Barić A; Kaličanin D; Punda A; Polašek O; Vukojević K; Zemunik T
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003522
[TBL] [Abstract][Full Text] [Related]
2. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.
Wichert B; Milde-Langosch K; Galatenko V; Schmalfeldt B; Oliveira-Ferrer L
Glycobiology; 2018 Nov; 28(11):898-903. PubMed ID: 30016515
[TBL] [Abstract][Full Text] [Related]
5. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
6. Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.
Chai YJ; Kim YA; Jee HG; Yi JW; Jang BG; Lee KE; Park YJ; Youn YK
Surgery; 2014 Dec; 156(6):1559-67; discussion 1567-8. PubMed ID: 25456955
[TBL] [Abstract][Full Text] [Related]
7. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features.
Cho U; Mete O; Kim MH; Bae JS; Jung CK
Mod Pathol; 2017 Jun; 30(6):810-825. PubMed ID: 28281551
[TBL] [Abstract][Full Text] [Related]
8. Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Giordano TJ
Curr Opin Oncol; 2016 Jan; 28(1):1-4. PubMed ID: 26569424
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma.
Liu R; Cao X; Liang Y; Li X; Jin Q; Li Y; Du H; Zao X; Ye Y
J Inflamm Res; 2022; 15():5801-5814. PubMed ID: 36238765
[TBL] [Abstract][Full Text] [Related]
10. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
11. Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.
Venturi G; Gomes Ferreira I; Pucci M; Ferracin M; Malagolini N; Chiricolo M; Dall'Olio F
Glycobiology; 2019 Sep; 29(10):684-695. PubMed ID: 31317190
[TBL] [Abstract][Full Text] [Related]
12. Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism.
Jones RB; Silva AD; Ankenbauer KE; Britain CM; Chakraborty A; Brown JA; Ballinger SW; Bellis SL
Glycobiology; 2023 Oct; 33(8):626-636. PubMed ID: 37364046
[TBL] [Abstract][Full Text] [Related]
13. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
[TBL] [Abstract][Full Text] [Related]
14. Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features.
Wahid MHA; Almudhafar RH
J Med Life; 2022 Apr; 15(4):520-525. PubMed ID: 35646190
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variants in the
Matana A; Popović M; Boutin T; Torlak V; Brdar D; Gunjača I; Kolčić I; Boraska Perica V; Punda A; Rudan I; Polašek O; Barbalić M; Hayward C; Zemunik T
Thyroid; 2019 Jun; 29(6):886-893. PubMed ID: 30929638
[No Abstract] [Full Text] [Related]
16. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
Xu B; Serrette R; Tuttle RM; Alzumaili B; Ganly I; Katabi N; Tallini G; Ghossein R
Thyroid; 2019 Dec; 29(12):1792-1803. PubMed ID: 31452453
[No Abstract] [Full Text] [Related]
17. Deregulated expression of VHL mRNA variants in papillary thyroid cancer.
Baldini E; Tuccilli C; Arlot-Bonnemains Y; Chesnel F; Sorrenti S; De Vito C; Catania A; D'Armiento E; Antonelli A; Fallahi P; Watutantrige-Fernando S; Tartaglia F; Barollo S; Mian C; Bononi M; Arceri S; Mascagni D; Vergine M; Pironi D; Monti M; Filippini A; Ulisse S
Mol Cell Endocrinol; 2017 Mar; 443():121-127. PubMed ID: 28089820
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
19. FNA diagnosis of a metastatic papillary thyroid carcinoma arising from a previously unknown follicular variant of papillary thyroid microcarcinoma.
Jedrzkiewicz J; Witt BL
Diagn Cytopathol; 2014 Aug; 42(8):711-5. PubMed ID: 23913830
[TBL] [Abstract][Full Text] [Related]
20. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
